Is LNAI research on Rallies investment advice?

No. Rallies provides research, data, and educational context for LNAI. It does not provide personalized investment advice.

LNAI (Lunai Bioworks Inc. Common Stock) Stock Analysis - Financials

Lunai Bioworks Inc. Common Stock (LNAI) is a publicly traded the market company. As of August 4, 2026, LNAI trades at $2.43 with a market cap of $8.80M and a P/E ratio of 0.00. LNAI moved +5.02% today. Year to date, LNAI is -66.12%; over the trailing twelve months it is flat. Its 52-week range spans $1.21 to $13.28. Rallies surfaces LNAI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are LNAI's key financials?

LNAI financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. LNAI recently traded at $2.43. Market cap is $8.80M. P/E ratio is 0.00. Revenue is $0.

LNAI Key Metrics

Key financial metrics for LNAI
Metric	Value
Price	$2.43
Market Cap	$8.80M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$13.28
52-Week Low	$1.21
Volume	173.90K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

LNAI Analyst Consensus

LNAI analyst coverage data. Average price target: $0.00.

Common questions about LNAI

What are LNAI's key financials?: LNAI financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. LNAI recently traded at $2.43. Market cap is $8.80M. P/E ratio is 0.00. Revenue is $0.
Is LNAI research on Rallies investment advice?: No. Rallies provides research, data, and educational context for LNAI. It does not provide personalized investment advice.